Cite Filings / TARS / 0000102909-26-002452

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Tarsus Pharmaceuticals, Inc. Filed 2026-03-27 Acc 0000102909-26-002452

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-05-06 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-03-27 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-03-24 4 Chief Operating Officer sold 2,989 shares at $66.75 ($199,516)
2026-03-20 144 Sale of Securities
2026-02-17 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…